| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.04B | — | +33.1% |
| R&D Expense | $398.0M | — | +30.1% |
| SG&A Expense | $432.0M | — | +30.1% |
| Operating Income | $151.0M | — | -2.6% |
| Pre-tax Income | $191.0M | — | -3.5% |
| Income Tax | $8.0M | — | +33.3% |
| Net Income | $184.0M | — | -4.7% |
| EPS (Basic) | $0.42 | — | -8.7% |
| EPS (Diluted) | $0.42 | — | -4.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.58B | +4.5% | +1.7% |
| Accounts Receivable | $1.03B | -6.7% | +32.2% |
| Current Assets | $8.59B | -0.6% | +9.4% |
| Total Assets | $19.71B | +0.3% | +45.2% |
| Current Liabilities | $6.03B | -2.0% | +31.7% |
| Total Liabilities | $9.50B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $594.0M | — | -6.5% |
| Capital Expenditures | $57.0M | — | -23.0% |
| Investing Cash Flow | -$98.0M | — | +38.8% |
| Financing Cash Flow | -$173.0M | — | -5866.7% |
| Free Cash Flow | $537.0M | — | -4.3% |
| +83.5% |
| Stockholders' Equity | $10.20B | +1.6% | +21.6% |